Clinical Trial Update: Prospective Research on the Intervention of Myoless2.0 Effectiveness (PRIME) in Pediatric Population

View source ↗

Summary

This entry describes the PRIME prospective study evaluating Myoless2.0 for myopia progression in children. The trial is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myopia

Drugs mentioned

• Myoless2.0

Snippet

Sponsor: Indizen Optical Technologies, S.L.U. | Conditions: Myopia Progression | Status: NOT_YET_RECRUITING